[Skip to Content]
[Skip to Content Landing]
Article
January 27, 1993

Antineoplastons: The Controversy Continues

JAMA. 1993;269(4):475. doi:10.1001/jama.1993.03500040041027
Abstract

To the Editor.  —As a paid consultant to those formerly in litigation against me, Dr Green1 can scarcely be considered impartial. Not surprisingly, Green gravely misrepresents more than 20 years of research. Due to space constraints, I can address only a few of Green's misstatements, and therefore am unable to counter one of the most serious problems of the article, Green's omission of dozens of publications.Green disputes my claim to a PhD degree in biochemistry and asserts that my bibliography does not identify a dissertation. The sworn affidavit of Professor Zdzislaw Kleinrok, president of the Medical Academy of Lublin, Poland, confirms that my PhD in biochemistry was awarded on October 16,1968. My doctoral dissertation2 is always listed in my bibliography.Green refers to tests done by the National Cancer Institute (NCI) as "compelling evidence of the lack of efficacy of antineoplastons against experimental cancer." Green fails to

×